Member Info for Dibs61

An article from Share Prophets by Paddington B. "IPSA (IPSA) is a company that was established to develop, own and operate power generation capacity in southern Africa. Things have not worked out fantastically for the company. It has a market capitalisation of three and a half million sterling. It also has net debt of more than eight million. Debt is a significant problem for this company. I note recent RNS statements: 27th March: The Company obtained a short term loan of £4.2m with a maturity of 90 days. 26th April: The Company extended the loan by £0.75m. And something not announced: 10th May: The Company had a CCJ registered against it for almost £50,000 in a Manchester court (case reference number 2YN71984) Back to the RNS statements 10th June: The company agreed a sale of two turbines to Rurelec (from the RNS it states: “Peter Earl and Elizabeth Shaw are directors of both IPSA and Rurelec”). The transaction was for £16.1m, £4.2 of which will be deferred, possibly for some time. The initial consideration will be funded by the allotment of shares in Rurelec From that RNS the company also states: “creditors, holding approximately £9.9 million of outstanding loans, have each agreed to accept Rurelec Shares and cancel their loans to IPSA in full, subject to their Rurelec Shares being duly admitted to trading on AIM.” That will deal with the loan due tomorrow. Phew… The company carried on, on 10th June, to say: “Currently, IPSA has significant indebtedness and is reliant on the continuing co-operation of its creditors. In particular the Bluestone loans totalling approximately £6.3 million need to be repaid on or before 27 June 2013.” You now understand the urgency of this sale. But what of the other creditors including whoever took the CCJ out against the company. Are they happy to be paid in Rurelec shares? Or can IPSA place the shares it has out in an orderly manner (as it says it intends to do) to clear its other debts including £1.8 million owed to its directors? What happens if Rurelec shares start to slide? And what will IPSA actually do going forward? It admits that working capital will continue to be tight – if Rurelec shares slide make that very tight. At a market cap of less than £4 million it might be argued that the bad news is in the price. I am not so sure."

They have to announce their results this week or under the regulations they will be suspended. I guess that would be the final insult! They don't seem to want to communicate anything to the market though, over 3 months now! Pull your bloody fingers out Petroneft!

Paisley - I am particularly intrigued by the NowWeComply integration as this marks a step into a different software application area and therefore an expansion of their market (out of CRM). Something I have been watching for having quizzed Simon Cleaver about it at the AGM. He had passed the question over to MS who basically said 'yes'. The fact that CloudCall has been integrated with Outlook tells you that it has capabilities beyond CRM.

Because our business model involves integrating our product (as an add on) to partners CRM applications once we have reached critical mass our fortunes are, to some extent, tied to those of our integration partners. So the stronger and more growth hungry they are the better for us. Of course I do also expect Synety to expand and upgrade our product range also as a means to provide growth.

Check out this article for a rundown on the prospects for the future of CRM: http://www.zdnet.com/son-of-crm-cloud-sales-marketing-and-service-in-2013-7000009729/ I particularly liked this extract by the writer: "There is only one 800lb gorilla in the jungle of cloud CRM: Salesforce.com. So much so that a few months back, I accused the company of turning into a latter-day Oracle in its pursuit of growth. It certainly has the scale, expense-account sales teams and corporate relationships of a classic enterprise software vendor. It's so dominant in its core domain of cloud-based salesforce automation that few dare to challenge it there, while it's built considerable strength in the neighbouring domain of customer service. As the largest and best known pureplay cloud vendor, it has long been the pre-eminent evangelist of cloud applications in the enterprise, and more recently of social business." Salesforce.com are a leading integration partner to Synety. So, they grow - we grow.

Yes, it's over a year old but gives a flavour of why customers take CloudCall and the benefits it provides to them (this link is through Salesforce - more to come on them in a minute ;-) http://salesforce-news.tmcnet.com/news/2012/04/26/6279647.htm

From the Salesforce website. For those that are unaware Salesforce are one of Synetys leading integration partners. https://www.salesforce.com/form/pdf/gartner-customer-service-magic-quadrant-2013.jsp Let me ask this question. If you were a company using CRM and were taking it to the Cloud (which you will if you haven't already) would you want to be left behind in the market by not having Synetys business enhancing technology? No brainer.

Excellent stuff. Mark ably illustrating the benefits of CloudCall as well as demonstrating the importance of CRM to businesses and how CloudCall integrates with it. Great to see them targeting recruitment where CRM should be used widely. Also interesting to hear them mention they are themselves recruiting and expanding their sales team.. I wonder why? ;-)

Thanks for info. :-) Hows L2 looking today, fair few trades going through.

Looks like all 5 trades thus far are BUYS. Not concerned about the illiquidity in this stock. It's the company, their plans, growth, business model and prospects that truly count. The rest will take care of itself. If it's good enough (which it is) the illiquidity will work to our advantage. :-)

SNTY back on the charge.... and some! Great company, fantastic growth prospects. Not too late for doubters. ;-) DYOR. Thoroughly. The more you do the more convinced you will become.

Castaway - yes I have been topping up at these low levels. Greedy when others fearful and all that..... Got my average down to 3.8 now so it wouldnt take a huge push north to get me back into positive territory. Sooner or later this is going to turn and when it does it could happen quite rapidly.

Certainly somebody was taking some bites today. I wonder if this finally signifies the bottom. Someone on ADVFN reckons we have halted the 10 month downtrend, we'll see. I do have a strong feeling that some people will be kicking themselves for not buying at this level in a few weeks. Results due by end June - clearly they will NOT be good - that is what the SP is telling us. However, it is not the historical stuff I will be focusing on but post results progress operationally, farm out(?) debt reduction and prospects going forward. Will be interesting.

So, today we have had a volume of 238,072 and, of that figure, 30,000 were sells leaving 208,072 as buys. And we are 0.125p DOWN. What a joke. And we are supposed to think that the price is always a reflection of supply and demand.

Now this is a rare phenomenon I can dummy sell my entire holding (and not the usual NT on PTR) for 2.95p but I can buy the same amount for only 2.91p! Anyone care to comment on what is going on?

I'm encouraged by that 1m buy earlier this morning. Someone's confident enough to stick a big wedge like that in.....

A little flurry of trades just gone through. Is anyone out there?

I've bought an initial holding here. Like this a lot and been following for a while. Great product and a totally revised business model established. Relatively new management appear to be making excellent progress. A good entry point hopefully in advance of the preliminary results next week. Probably won't be break even yet for y/e 31.3.2013 but we should get a post year end update which should give a good indication where we are headed so far this year.

Down to 3.36p now in old money. In these kind of investments you can do one of three things. You can sell (silly). Or you can just pledge to switch off and not come back for 6 mths, or a year or so (unrealistic). Or you can remind yourself what made you invest in the first place and that's what I've done here. I've read back through some of the stuff that I researched originally and it's rekindled my enthusiasm for this stock. Very shrewd investors have put substantial stakes in here. This is only one of two companies worldwide that are using RNAi technology. The company has excellent management with a clear vision. They are now fully funded for the next two years or so. By then Atu027 should have completed Phase II trials completely and hopefully have reached a high value inflexion point. In addition hopefully their drug portfolio would have widened considerably using their three technology platforms and be progressing nicely. That's it I've convinced myself again, it wasn't hard!

A modest rise but welcome nonetheless while we await further developments in the rapid growth of this exciting company.